US Stock MarketDetailed Quotes

XERS Xeris Pharmaceuticals

Watchlist
  • 1.750
  • +0.050+2.94%
Close Apr 26 16:00 ET
  • 1.750
  • 0.0000.00%
Post 19:56 ET
259.44MMarket Cap-3888P/E (TTM)

Xeris Pharmaceuticals Key Stats

Xeris Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 6, 2024

Revenue(YoY)

44.39M

+33.93%
EPS(YoY)

-0.09

+10.00%

Strong Buy

Apr 4, 2024

Xeris Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 45.096M--
--2024/Q1-- / 41.815M--
Mar 6, 20242023/Q444.390M / 43.552M--
Nov 9, 20232023/Q348.320M / 41.084M--
Aug 8, 20232023/Q238.008M / 34.838M--
May 9, 20232023/Q133.196M / 30.765M--
Mar 8, 20232022/Q433.144M / 31.038M--
Nov 9, 20222022/Q329.725M / 29.123M--
--2022/Q225.306M / 25.531M--
May 11, 20222022/Q122.073M / 23.393M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 45.096M--
--2024/Q1-- / 41.815M--
Mar 6, 20242023/Q444.390M / 43.552M--
Nov 9, 20232023/Q348.320M / 41.084M--
Aug 8, 20232023/Q238.008M / 34.838M--
May 9, 20232023/Q133.196M / 30.765M--
Mar 8, 20232022/Q433.144M / 31.038M--
Nov 9, 20222022/Q329.725M / 29.123M--
--2022/Q225.306M / 25.531M--
May 11, 20222022/Q122.073M / 23.393M--

Unlock Free Earnings Estimates

Xeris Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 4, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg